Log In Get Started

News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • India will continue bilateral trade talks with the U.S. after Washington imposed a 10% tariff on about 55% of Indian exports.
  • Brazil refused visas for two U.S. officials, raising bilateral tensions ahead of Brazil's October presidential election.
  • Analysts pitch tactical buy trades across sectors: fintech (SoFi), gaming (Take-Two), semiconductors (AMD), aviation (Joby), and small caps.
  • AMD is positioned to benefit from rising AI infrastructure demand, prompting a bullish trade setup despite rich valuation.
  • Broadcasters like Gray Media are being bought ahead of expected political-ad spending into the 2026 cycle.
  • Royalty names (Gold Royalty, Kimbell) are recommended for improving cash flow and potential re-rating as production and acquisitions accelerate.

Latest Articles

Enlivex Treasury Portfolio Update: Rain Protocol Jumps Into Top Three Global Prediction Markets In League Table Following $100M In Additional Liquidity
May 27, 2026
Priya Menon
Press Releases

Enlivex Treasury Portfolio Update: Rain Protocol Jumps Into Top Three Global Prediction Markets In League Table Following $100M In Additional Liquidity

Enlivex Ltd. (Nasdaq: ENLV), a clinical-stage immunotherapy company, highlights the Rain Protocol's $100 million liquidity injection, placing Rain among the top three global prediction market platforms by total value locked. Enlivex holds substantial RAIN tokens and an option to acquire more, underpinning confidence in its dual strategy combining l…

ENLV
New IMPACT Phase 2b Data Highlight Concurrent Improvements Across Multiple Non-Invasive Markers and qFibrosis-Measured Fibrosis Regression with Pemvidutide in MASH at EASL 2026
May 27, 2026
Marcus Reed
Press Releases

New IMPACT Phase 2b Data Highlight Concurrent Improvements Across Multiple Non-Invasive Markers and qFibrosis-Measured Fibrosis Regression with Pemvidutide in MASH at EASL 2026

Altimmune, Inc. announced new analyses from its IMPACT Phase 2b trial showing pemvidutide, a novel glucagon/GLP-1 dual receptor agonist, significantly improves multiple non-invasive markers of metabolic dysfunction-associated steatohepatitis (MASH) activity and fibrosis after 24 weeks of treatment. AI-based digital pathology further confirmed antif…

ALT
4DMT to Participate in Upcoming Investor Conferences
May 27, 2026
Sofia Navarro
Press Releases

4DMT to Participate in Upcoming Investor Conferences

4D Molecular Therapeutics announced participation in upcoming June investor conferences, where company management will present and hold one-on-one meetings. The biotech firm is advancing late-stage gene therapy candidates targeting serious conditions such as wet age-related macular degeneration and cystic fibrosis, with multiple programs in clinica…

FDMT
Galectin Therapeutics Presents New EASL 2026 Oral and Poster Analyses Demonstrating Belapectin’s Potential to Modify Disease Progression in Advanced MASH Cirrhosis
May 27, 2026
Marcus Reed
Press Releases

Galectin Therapeutics Presents New EASL 2026 Oral and Poster Analyses Demonstrating Belapectin’s Potential to Modify Disease Progression in Advanced MASH Cirrhosis

Galectin Therapeutics presented new analyses from the NAVIGATE trial at the EASL 2026 Congress, showing that belapectin significantly reduces varices development and improves markers of fibrosis and portal hypertension risk in patients with advanced MASH cirrhosis. The data support belapectin's role as a disease-modifying therapy targeting fibrotic…

GALT
Live Oak Bank Grant Fuels Workforce Mobility Through The Forward Fund
May 27, 2026
Sofia Navarro
Press Releases

Live Oak Bank Grant Fuels Workforce Mobility Through The Forward Fund

Live Oak Bank has committed $1 million over five years to The Forward Fund, a North Carolina-based pay-it-forward financing program. The initiative provides zero-percent interest loans to working adults for career training in high-demand fields, fostering workforce upskilling and economic mobility. In its first year, the program issued $2.3 million…

LOB
Mesa Labs Announces Fourth Quarter and Fiscal Year 2026 Results
May 27, 2026
Maya Rios
Press Releases

Mesa Labs Announces Fourth Quarter and Fiscal Year 2026 Results

Mesa Laboratories, Inc. announced its fiscal year 2026 financial results, reporting 3.4% revenue growth driven primarily by its Sterilization and Disinfection Control division, offset by declines in Biopharmaceutical Development due to export controls and commercial execution challenges. Operating income rose 13.3%, aided by cost realignment and ba…

MLAB
Mid‑Market Companies Lose an Average of 25% of Their AI Budget Before Seeing a Single Return, New Freshworks Research Finds
May 27, 2026
Jordan Park
Press Releases

Mid‑Market Companies Lose an Average of 25% of Their AI Budget Before Seeing a Single Return, New Freshworks Research Finds

Freshworks Inc. releases a report detailing how mid-market companies lose on average 25% of their AI budgets to complexity overhead before achieving returns, with increased workload and integration challenges delaying ROI realization. Despite these hurdles, most mid-market organizations plan to increase AI investments, focusing on AI solutions that…

FRSH
Avalyn to Participate in the Jefferies Global Healthcare Conference
May 27, 2026
Hana Yamamoto
Press Releases

Avalyn to Participate in the Jefferies Global Healthcare Conference

Avalyn Pharma Inc., a clinical-stage biopharmaceutical company focused on inhaled therapies for serious respiratory diseases, announced that its management will present an overview of the company at the Jefferies Global Healthcare Conference. The presentation will cover Avalyn's development of inhaled formulations of antifibrotic drugs targeting pu…

AVLN
Pacira BioSciences Reports Real-World Study Showing EXPAREL® Use Was Associated with Reduced Opioid Use and Healthcare Costs in Patients Undergoing Total Shoulder Arthroplasty
May 27, 2026
Derek Hwang
Press Releases

Pacira BioSciences Reports Real-World Study Showing EXPAREL® Use Was Associated with Reduced Opioid Use and Healthcare Costs in Patients Undergoing Total Shoulder Arthroplasty

Pacira BioSciences reports real-world study findings showing that use of EXPAREL, their non-opioid pain therapy, in outpatient total shoulder arthroplasty patients led to reduced opioid use, fewer opioid-related adverse events, and lower healthcare costs compared to standard analgesia. These findings support the expanding role of non-opioid pain ma…

PCRX
GrowGeneration to Participate in the Oppenheimer 26th Annual Consumer Growth and E-Commerce Conference on June 10, 2026
May 27, 2026
Marcus Reed
Press Releases

GrowGeneration to Participate in the Oppenheimer 26th Annual Consumer Growth and E-Commerce Conference on June 10, 2026

GrowGeneration Corp., a major supplier of specialty products for controlled environment agriculture and commercial cultivation, announced its management team's upcoming participation in the Oppenheimer 26th Annual Consumer Growth and E-Commerce Conference on June 10, 2026. CEO Darren Lampert and CFO Gregory Sanders will engage in a Fireside Chat an…

GRWG
Abacus Global Management and Manning & Napier Enter into Strategic Alliance Agreement and Announce Closing of Minority Investment
May 27, 2026
Priya Menon
Press Releases

Abacus Global Management and Manning & Napier Enter into Strategic Alliance Agreement and Announce Closing of Minority Investment

Abacus Global Management has entered into a strategic alliance with Manning & Napier, including a minority equity investment of approximately $53 million. This partnership leverages Abacus's proprietary longevity data and actuarial expertise alongside Manning & Napier's wealth management platform, aiming to create enhanced lifespan-based financial …

ABX
Dudick Promoted to SVP, Team Leader at Provident Bank
May 27, 2026
Priya Menon
Press Releases

Dudick Promoted to SVP, Team Leader at Provident Bank

Provident Bank has promoted Jessica Dudick to Senior Vice President, Team Leader of the Monmouth/Ocean Commercial & Industrial lending team. Dudick will manage relationship managers and lending specialists focused on small- to mid-sized business lending and deposit/treasury solutions in New Jersey. She brings over 20 years of experience and will le…

PFS